Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

GSK takes Otravine’s air-purifying bubble to COP26

GlaxoSmithKline (GSK) has taken an “educational architecture” piece that purifies the air to the 26th Conference of the Parties (COP26) in Glasgow, to flag the devastating effect of air pollution on children’s health.

The inflatable structure, which is called the Air Bubble, uses microalgae to actively filter and re-metabolise pollution particles and carbon dioxide, allowing its visitors to experience cleaner air, GSK said.

Through it, Otrivine “is demonstrating how innovative nature-based technology can expand the functionality of our nose to ‘clean’ the air we breathe in polluted urban environments”, the manufacturer added.

The Air Bubble is part of Otravine’s Actions to Breathe Cleaner campaign, which involves more than 1,000 school children tracking air quality in their area.

As part of the campaign, the participating children also receive education about the small, personal daily actions they can take to help them breathe cleaner.

To learn what actions you can take to mitigate the impact of air pollution, visit Otravine’s YouTube channel

Related Content

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD135706

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel